Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1995-5-9
|
pubmed:abstractText |
Cell kinetics is a predictive parameter of breast-cancer aggressiveness, and mutations occurring in mammary tumorigenesis may favor uncontrolled cell proliferation. In this study, cell kinetics, clinico-pathological characteristics and genetic alterations at the int-2, bcl-1, c-myc, c-erbB-2, and DF3 loci were analyzed and correlated in 54 primary breast carcinomas. The occurrence of mutations at more than one locus was also studied. Tumor-proliferative activity was evaluated by determination of the thymidine labeling index (TLI). Amplification (AMP) of int-2 was observed in 11.2%, of bcl-1 in 9.4%, of c-myc in 5.7% and of c-erbB-2 in 8.6% of the carcinomas. Loss of heterozygosity (LOH) at the DF3 locus was detected in 13.9% of the tumors. Genetic alterations demonstrated a significant association with patient's age and high TLI values. AMP and LOH+AMP did not appear to be statistically related to histotype, histological grade, tumor size or lymph-node status. Alone, allele loss at the DF-3 locus was not significantly associated with any of the clinico-pathological characteristics studied. Alterations at more than one locus, including int-2/bcl-1, int-2/c-myc, int-2/bcl-1/c-erbB-2, and c-myc/DF3, were detected in 11.1% of the tumors. Multiple mutations were found only in less differentiated tumors, which included the 2 cases from the youngest patients of the series.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
29
|
pubmed:volume |
61
|
pubmed:geneSymbol |
bcl-1,
c-myc,
erbB-2,
int-2,
myc
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
1-6
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:7705920-Adult,
pubmed-meshheading:7705920-Aged,
pubmed-meshheading:7705920-Breast Neoplasms,
pubmed-meshheading:7705920-Cell Cycle,
pubmed-meshheading:7705920-Female,
pubmed-meshheading:7705920-Gene Amplification,
pubmed-meshheading:7705920-Gene Deletion,
pubmed-meshheading:7705920-Heterozygote,
pubmed-meshheading:7705920-Humans,
pubmed-meshheading:7705920-Middle Aged,
pubmed-meshheading:7705920-Mutation,
pubmed-meshheading:7705920-Proto-Oncogenes
|
pubmed:year |
1995
|
pubmed:articleTitle |
High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers.
|
pubmed:affiliation |
Department of Experimental Medicine, University of Rome La Sapienza, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|